Hemispherix Biopharma (HEB) Files $150M Mixed Shelf
Tweet Send to a Friend
Hemispherix Biopharma, Inc. (NYSE: HEB) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Debt Securities, Preferred Stock, Common Stock, Debt Warrants, Equity Warrants, Units, or any combination thereof.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Calumet Specialty Products (CLMT) Files $300M Common, Debt Shelf
- DDR Corp. (DDR) Commences 32M Common Share Offering
- Rose Rock Midstream (RRMS) Files $500M Mixed Shelf; 12.5M Common Units for Holders
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
